Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.04
SMA's Cash to Debt is ranked lower than
61% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 6.28 vs. SMA: 0.04 )
SMA' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.04

Equity to Asset 0.55
SMA's Equity to Asset is ranked higher than
58% of the 358 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SMA: 0.55 )
SMA' s 10-Year Equity to Asset Range
Min: -0.03   Max: 0.75
Current: 0.55

-0.03
0.75
F-Score: 5
Z-Score: 1.36
M-Score: -3.30
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) -7.09
SMA's Operating margin (%) is ranked higher than
54% of the 363 Companies
in the Global Medical Devices industry.

( Industry Median: 6.75 vs. SMA: -7.09 )
SMA' s 10-Year Operating margin (%) Range
Min: -7.09   Max: 18.38
Current: -7.09

-7.09
18.38
Net-margin (%) -8.95
SMA's Net-margin (%) is ranked higher than
53% of the 363 Companies
in the Global Medical Devices industry.

( Industry Median: 5.06 vs. SMA: -8.95 )
SMA' s 10-Year Net-margin (%) Range
Min: -9.69   Max: 7.56
Current: -8.95

-9.69
7.56
ROE (%) -12.57
SMA's ROE (%) is ranked higher than
53% of the 363 Companies
in the Global Medical Devices industry.

( Industry Median: 5.79 vs. SMA: -12.57 )
SMA' s 10-Year ROE (%) Range
Min: -12.57   Max: 9.52
Current: -12.57

-12.57
9.52
ROA (%) -6.94
SMA's ROA (%) is ranked higher than
55% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. SMA: -6.94 )
SMA' s 10-Year ROA (%) Range
Min: -9.55   Max: 5.3
Current: -6.94

-9.55
5.3
ROC (Joel Greenblatt) (%) -16.60
SMA's ROC (Joel Greenblatt) (%) is ranked higher than
57% of the 376 Companies
in the Global Medical Devices industry.

( Industry Median: 12.75 vs. SMA: -16.60 )
SMA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -16.6   Max: 30.56
Current: -16.6

-16.6
30.56
Revenue Growth (%) 3.00
SMA's Revenue Growth (%) is ranked higher than
67% of the 278 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. SMA: 3.00 )
SMA' s 10-Year Revenue Growth (%) Range
Min: -12.3   Max: 16.9
Current: 3

-12.3
16.9
» SMA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

SMA Guru Trades in Q1 2013

Joel Greenblatt 163,685 sh (+166.77%)
Jim Simons 89,900 sh (+86.9%)
John Keeley 2,033,694 sh (+5.28%)
John Rogers 4,300,731 sh (-5.52%)
» More
Q2 2013

SMA Guru Trades in Q2 2013

Chuck Royce 218,100 sh (New)
Paul Tudor Jones 55,900 sh (New)
Jim Simons 205,900 sh (+129.03%)
Joel Greenblatt 248,934 sh (+52.08%)
John Keeley Sold Out
John Rogers 4,028,701 sh (-6.33%)
» More
Q3 2013

SMA Guru Trades in Q3 2013

Chuck Royce 274,000 sh (+25.63%)
Joel Greenblatt 263,581 sh (+5.88%)
John Rogers 4,041,726 sh (+0.32%)
Paul Tudor Jones 35,300 sh (-36.85%)
Jim Simons 20,900 sh (-89.85%)
» More
Q4 2013

SMA Guru Trades in Q4 2013

John Rogers 4,892,085 sh (+21.04%)
Chuck Royce 323,800 sh (+18.18%)
Jim Simons Sold Out
Joel Greenblatt 230,413 sh (-12.58%)
Paul Tudor Jones 15,399 sh (-56.38%)
» More
» Details

Insider Trades

Latest Guru Trades with SMA

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Keeley 2013-06-30 Sold Out 0.46%$7.73 - $12.7 $ 8.96-13%0
Joel Greenblatt 2013-06-30 Add 52.08%0.03%$7.73 - $12.7 $ 8.96-13%248934
Joel Greenblatt 2013-03-31 Add 166.77%0.06%$10.13 - $11.45 $ 8.96-17%163685
Joel Greenblatt 2012-12-31 New Buy0.04%$8.27 - $10.61 $ 8.96-5%61357
John Keeley 2012-09-30 Add 294.53%0.28%$7.51 - $10.02 $ 8.961%1751694
John Keeley 2012-06-30 New Buy0.09%$6.7 - $8.71 $ 8.9618%444000
Joel Greenblatt 2011-09-30 Sold Out 0.0137%$7.27 - $10.01 $ 8.965%0
George Soros 2011-09-30 Sold Out 0.0026%$7.27 - $10.01 $ 8.965%0
Joel Greenblatt 2011-06-30 Reduce -26.17%0.01%$8.44 - $10.22 $ 8.96-6%10976
George Soros 2011-06-30 New Buy$8.44 - $10.22 $ 8.96-6%21000
Joel Greenblatt 2011-03-31 New Buy0.04%$8.63 - $9.94 $ 8.96-4%14867
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 1.17
SMA's P/B is ranked higher than
87% of the 355 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. SMA: 1.17 )
SMA' s 10-Year P/B Range
Min: 0.61   Max: 3.67
Current: 1.17

0.61
3.67
P/S 0.82
SMA's P/S is ranked higher than
87% of the 378 Companies
in the Global Medical Devices industry.

( Industry Median: 2.80 vs. SMA: 0.82 )
SMA' s 10-Year P/S Range
Min: 0.37   Max: 3.1
Current: 0.82

0.37
3.1
PFCF 9.05
SMA's PFCF is ranked higher than
96% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 27.48 vs. SMA: 9.05 )
SMA' s 10-Year PFCF Range
Min: 6.67   Max: 198
Current: 9.05

6.67
198
Shiller P/E 45.47
SMA's Shiller P/E is ranked lower than
53% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 26.95 vs. SMA: 45.47 )
SMA' s 10-Year Shiller P/E Range
Min: 17.89   Max: 54.5
Current: 45.47

17.89
54.5

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.73
SMA's Price/DCF (Projected) is ranked higher than
94% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SMA: 0.73 )
SMA' s 10-Year Price/DCF (Projected) Range
Min: 0.79   Max: 1.04
Current: 0.73

0.79
1.04
Price/Median PS Value 0.84
SMA's Price/Median PS Value is ranked higher than
84% of the 334 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. SMA: 0.84 )
SMA' s 10-Year Price/Median PS Value Range
Min: 0.68   Max: 2.64
Current: 0.84

0.68
2.64
Earnings Yield (Greenblatt) 5.10
SMA's Earnings Yield (Greenblatt) is ranked higher than
71% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 4.50 vs. SMA: 5.10 )
SMA' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 16
Current: 5.1

1.5
16
Forward Rate of Return (Yacktman) 6.36
SMA's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. SMA: 6.36 )
SMA' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -15   Max: 35.2
Current: 6.36

-15
35.2

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, ZMH, STJ, EW » details
Traded in other countries:RZV.Germany
Symmetry Medical, Inc., is a Delaware corporation incorporated on July 25, 1996. It is a source of medical device products. The Company provides medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. It operates in two reportable segments namely Original Equipment Manufacturer ("OEM") Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation ("SSI"). Symmetry Surgical, which is headquartered in Nashville,Tennessee. Symmetry Surgical offers reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are typically used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide